XML 25 R14.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Loss Per Common Share
6 Months Ended
Jun. 30, 2024
Loss Per Common Share  
Loss Per Common Share

8. Loss Per Common Share

 

The Company presents the computation of earnings per share (“EPS”) on a basic basis. Basic EPS is computed by dividing net income or loss by the weighted average number of shares outstanding during the reported period. Diluted EPS is computed similarly to basic EPS, except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential additional common shares that were dilutive had been issued. Common shares are excluded from the calculation if they are determined to be anti-dilutive. The following table sets forth the weighted average number of common shares outstanding for each period presented.

 

 

 

For the three months ended

 

 

For the six months ended

 

June 30,

June 30,

 

 

 

2024

 

 

2023

 

 

2024

 

 

2023

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average number of common shares outstanding

 

 

10,503,599

 

 

 

7,003,599

 

 

 

10,436,647

 

 

 

7,003,599

 

Effect of dilutive securities:

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Weighted average number of dilutive common shares outstanding

 

 

10,503,599

 

 

 

7,003,599

 

 

 

10,436,647

 

 

 

7,003,599

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic and diluted loss per common share:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Continuing operations

 

$(0.12)

 

$(0.33)

 

$(0.32)

 

$(0.67)

Discontinued operations

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Consolidated operations

 

$(0.12)

 

$(0.33)

 

$(0.32)

 

$(0.67)

Approximately 1,766,547 and 8,232,510 shares of the Company’s common stock issuable upon the exercise of stock options and warrants, respectively, were excluded from the calculation because the effect would be anti-dilutive due to the loss for both the three and six months ended June 30, 2024.

 

Approximately 18,077 and 0 shares of the Company’s common stock issuable upon the exercise of stock options and warrants, respectively, were excluded from the calculation because the effect would be anti-dilutive due to the loss for the three months ended June 30, 2023.

 

Approximately 20,336 and 0 shares of the Company’s common stock issuable upon the exercise of stock options and warrants, respectively, were excluded from the calculation because the effect would be anti-dilutive due to the loss for the six months ended June 30, 2023.